1. Home
  2. chevron_right
  3. Publications


Shah A, Talley NJ, Koloski N, Macdonald GA, Kendall BJ, Shanahan ER, Walker MM, Keely S, Jones MP, Morrison M, Holtmann GJ. “Duodenal bacterial load as determined by quantitative polymerase chain reaction in asymptomatic controls, functional gastrointestinal disorders and inflammatory bowel disease.”, Alimentary Pharmacology & Therapeutics. 2020 May 15.

Prasad SS, Keely S, Talley NJ, Kairuz T, Walker MM. “Pharmacists’ Confidence in Managing Patients with Inflammatory Bowel Disease”. Pharmacy. 2020 Jun;8(2):68.

Chonwerawong M, Ferrand J, Chaudhry HM, Higgins C, Walker MM, Bhathal PS, Dev A, Moore GT, Sievert W, Jenkins BJ, D’Elios MM. “Innate Immune Molecule NLRC5 Protects Mice From Helicobacter-induced Formation of Gastric Lymphoid Tissue”. Gastroenterology. 2020 Mar 10.

Wauters L, Talley NJ, Walker MM, Tack J, Vanuytsel T. “Novel concepts in the pathophysiology and treatment of functional dyspepsia”. Gut. 2020 Mar 1;69(3):591-600.

Shah A, Talley NJ, Jones M, Kendall BJ, Koloski N, Walker MM, Morrison M, Holtmann GJ. “Small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis of case-control studies”. American Journal of Gastroenterology. 2020 Feb 1;115(2):190-201.

Potter MD, Jones MP, Walker MM, Koloski NA, Keely S, Holtmann G, Talley AC NJ. “Incidence and prevalence of self‐reported non‐coeliac wheat sensitivity and gluten avoidance in Australia”. Medical Journal of Australia. 2020 Feb;212(3):126-31.

Koloski NA, Jones M, Walker MM, Holtmann G, Talley NJ. “Functional dyspepsia is associated with lower exercise levels: A population-based study”. United European Gastroenterology Journal. 2020 Mar 30:2050640620916680.

Shah A, Macdonald GA, Morrison M, Holtmann G. “Targeting the Gut Microbiome as a Treatment for Primary Sclerosing Cholangitis: A Conceptional Framework”. American Journal of Gastroenterology. 2020 Jun 1;115(6):814-22.

Talley NJ, Irani M, Keely S. “Bacterial therapy for irritable bowel syndrome”. The lancet. Gastroenterology & Hepatology. 2020 Apr 8.

Wauters L, Burns G, Ceulemans M, Walker MM, Vanuytsel T, Keely S, Talley NJ. “Duodenal inflammation: an emerging target for functional dyspepsia?”. Expert Opinion on Therapeutic Targets. 2020 Jun 2;24(6):511-23.

Talley NJ. “What causes functional gastrointestinal disorders? A proposed disease model”. American Journal of Gastroenterology. 2020 Jan 1;115(1):41-8.

Keely S, Talley NJ. “Duodenal bile acids as determinants of intestinal mucosal homeostasis and disease”. Neurogastroenterology & Motility. 2020 May;32(5):e13854.

Liu G, Baird AW, Parsons MJ, Fan K, Skerrett‐Byrne DA, Nair PM, Makanyengo S, Chen J, Neal R, Goggins BJ, Tay H. “Platelet activating factor receptor acts to limit colitis‐induced liver inflammation”. The FASEB Journal. 2020 Apr 15.

Makanyengo SO, Carroll GM, Goggins BJ, Smith SR, Pockney PG, Keely S. “Systematic Review on the Influence of Tissue Oxygenation on Gut Microbiota and Anastomotic Healing”. Journal of Surgical Research. 2020 May 1;249:186-96.

Sokulsky LA, Goggins B, Sherwin S, Eyers F, Kaiko GE, Board PG, Keely S, Yang M, Foster PS. “GSTO1‐1 is an upstream suppressor of M2 macrophage skewing and HIF‐1α‐induced eosinophilic airway inflammation”. Clinical & Experimental Allergy. 2020 May;50(5):609-24.

deZoeten EF, Battista KD, Colson SB, Lovell MA, Kessler BE, Isfort RW, Fennimore BP, Onyiah JC, Kao DJ, Yeckes A, Keely S. “Markers of Hypoxia Correlate with Histologic and Endoscopic Severity of Colitis in Inflammatory Bowel Disease”. Hypoxia. 2020;8:1.

Shukla SD, Walters EH, Simpson JL, Keely S, Wark PA, O’Toole RF, Hansbro PM. “Hypoxia‐inducible factor and bacterial infections in chronic obstructive pulmonary disease”. Respirology. 2020 Jan;25(1):53-63.

Carroll GM, Burns GL, Petit JA, Walker MM, Mathe A, Smith SR, Keely S, Pockney PG. “Does postoperative inflammation or sepsis generate neutrophil extracellular traps that influence colorectal cancer progression? A systematic review”. Surgery Open Science. 2020 Apr 1;2(2):57-69.